Ignite Immunotherapy, Inc.
2Patents
2Active
2Granted
40Portfolio score
Filing activity: Jan 9, 2020 → Feb 10, 2020
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11685904B2 | Recombinant vaccinia virus and methods of use thereof | Chemistry; Metallurgy | 3 | Active |
| US11529402B2 | Recombinant vaccinia virus and methods of use thereof | Chemistry; Metallurgy | 3 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.